Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Lags Revenue Estimates
1/3 23:55
Avidity Biosciences, Inc. (RNA) came out with a quarterly loss of $0.82 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items....